JPMorgan (JPM) director Brad D. Smith defers annual stock grant
Rhea-AI Filing Summary
JPMorgan Chase director Brad D. Smith reported a deferred stock award under the company’s director compensation program. On 01/20/2026, he was credited with 913.5251 shares of common stock at a price of $306.505 per share, described as a deferral of his annual stock grant payable in shares upon termination of his service as a director. Following this transaction, he directly beneficially owned 2,946.5824 shares. The filing also lists additional indirect holdings in JPMorgan Chase common stock through family trusts, his spouse, a spouse’s GRAT, and a spouse’s IRA.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did JPM (JPMorgan Chase) report for Brad D. Smith?
Brad D. Smith, a director of JPMorgan Chase, reported an acquisition coded as "A" of 913.5251 shares of JPMorgan Chase common stock on 01/20/2026, tied to his annual director stock grant.
At what price was Brad D. Smith’s JPM director stock grant deferred?
The 913.5251 JPMorgan Chase common shares associated with Brad D. Smith’s deferred annual stock grant were recorded at a price of $306.505 per share.
How many JPM shares does Brad D. Smith directly own after this Form 4?
After the reported transaction, Brad D. Smith directly beneficially owned 2,946.5824 shares of JPMorgan Chase common stock.
What does the footnote on Brad D. Smith’s JPM Form 4 explain?
The footnote states that the transaction reflects a deferral of his annual stock grant, which will be paid in JPMorgan Chase shares upon his termination of service as a director.
What indirect JPM holdings related to Brad D. Smith are disclosed?
The Form 4 lists indirect beneficial ownership of 5,738 shares by family trusts, 1,000 shares by his spouse, 2,142 shares by his spouse’s GRAT, and 18 shares by his spouse’s IRA.
What is Brad D. Smith’s role at JPMorgan Chase in this Form 4?
Brad D. Smith is identified as a director of JPMorgan Chase, and the Form 4 is filed as a single reporting person.